Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
Yvan H. Chanthery(University of California, San Francisco), William A. Weiss(City College of San Francisco), Melissa Itsara(University of California, San Francisco), Christopher S. Hackett(Cornell University), Slava Yakovenko(University of California, San Francisco), Katherine K. Matthay(University of California System), Matthew Grimmer(Sequenom (United States)), Elise Charron(University of California, San Francisco), W. Clay Gustafson(Revolution Medicines (United States)), Anders I. Persson(University of California, San Francisco), Grace Kim(University of California, San Francisco)
Cited by 86
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
|BMC Medicine|2008|948
Targeted expression of MYCN causes neuroblastoma in transgenic mice
|The EMBO Journal|1997|870
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795